Pills found in ancient Tuscan wreck resemble modern medicine

by Bob Yirka report
The A/6 pyxis before it was opened (A) and the pyxis showing its contents (B). Credit: (c) PNAS. doi: 10.1073/pnas.1216776110

(Medical Xpress)—A team of Italian researchers studying the contents of a small tin found aboard the wreck of a second century B.C. cargo ship claim its contents are pills meant to cure eye or skin ailments. In their paper published in the Proceedings of the National Academy of Sciences, the team says that some of the ingredients found in the pills mirror those still used today to treat such ailments.

The tin, known as a pyxis was found after excavation of the wreck Relitto del Pozzino between 1989-90. The was first discovered in 1974 off the Tuscany coast and is believed to have met its fate in 140 B.C. The pyxis was found among other artifacts (a cup for blood-letting, vials, etc.) that led researchers to believe it belonged to a physician. Inside were small pills, each approximately 4 centimeters across and 1 centimeter thick. Careful analysis in the lab showed that the pills mostly contained zinc – approximately 75 percent – in the form of smithsonite. Other ingredients included animal and plant lipids, pine resin and starch. Because of the nature of their content, the researchers believe the were meant to be crushed and dissolved in water and then used as a topical agent to treat eye and skin problems.

In addition to the physical evidence, the researchers also cite the writings of Pliny the Elder and Dioscorides which both describe using zinc based compounds to treat eye and skin ailments. They called the medicine calamina – it was obtained by scraping the walls of copper furnaces. Later topical ointments using zinc ore based material were called calamine. They also point out that the Latin word, collyrium, means "small round loaves" and was derived from words that describe the use of an eyewash.

Together the evidence shows, the researchers claim, that early Roman and Etruscan physicians not only knew about the healing properties of but how to obtain and use them to treat patients. Finding an intact medicinal compound from such a long time ago is extremely rare, they note – and being able to connect it with the writings of noted physicians of the time makes the find all that much more profound.

More information: Ingredients of a 2,000-y-old medicine revealed by chemical, mineralogical, and botanical investigation, PNAS, Published online before print January 7, 2013, doi: 10.1073/pnas.1216776110

add to favorites email to friend print save as pdf

Related Stories

Zinc lozenges may shorten common-cold duration

Jul 26, 2011

Depending on the total dosage of zinc and the composition of lozenges, zinc lozenges may shorten the duration of common cold episodes by up to 40%, according to a study published in the Open Respiratory Medicine Journal.

Zinc lozenges may shorten common cold duration

Aug 16, 2011

Depending on the total dosage of zinc and the composition of lozenges, zinc lozenges may shorten the duration of common cold episodes by up to 40%, says Dr. Harri Hemila from the University of Helsinki.

Australians risking skin cancer to avoid nanoparticles

Feb 09, 2012

More than three in five Australians are concerned enough about the health implications of nanoparticles in sunscreens to want to know more about their impact. And while the initial scientific information released suggests ...

Recommended for you

Medical charity warns India over patent rules

Jan 21, 2015

Doctors without Borders on Wednesday warned the Indian government not to bow to US pressure to amend patent regulations that allow millions access to affordable medicines, ahead of a visit by President Barack Obama.

Why are some generic drugs getting so expensive?

Jan 21, 2015

More than eight out of every 10 prescriptions dispensed in the US is generic. This growth is due to a large number of top-selling drugs going off patent over the past decade, as well as innovations in t ...

Supreme Court sides with Teva in drug dispute

Jan 20, 2015

The Supreme Court on Tuesday sided with Teva Pharmaceutical Industries Ltd. in the company's high-profile patent dispute with rival firms over the top-selling multiple sclerosis drug.

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

daqddyo
4 / 5 (4) Jan 08, 2013
Sounds like a mighty big pill to swallow!
that_guy
3 / 5 (2) Jan 08, 2013
Sounds like a mighty big pill to swallow!

Good News! It's a suppository.

(I know it's actually a topical, so just laugh with me)

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.